Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Registry to Describe the Disease Course and Outcomes of Idiopathic Pulmonary Fibrosis Patients in a Real-world Clinical Setting. PROOF-Registry New and Extended Belgium -Luxembourg

NCT03732859 is registered in ClinicalTrials.gov with Belgian Thoracic Society as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03732859 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Registry to Describe the Disease Course and Outcomes of Idiopathic Pulmonary Fibrosis Patients in a Real-world Clinical Setting. PROOF-Registry New and Extended Belgium -Luxembourg
Lead sponsor
Belgian Thoracic Society
Phase
Observational
Overall status
Completed
Start date
January 9, 2018
Completion date
January 9, 2022
Enrollment
575 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.